COPD Connect
  • Saved
The Mind-Body-Breath Link During Oral Intake in Chronic Obstructive Pulmonary Disease: A Grounded Theory Analysis - Dysphagia

The Mind-Body-Breath Link During Oral Intake in Chronic Obstructive Pulmonary Disease: A Grounded Theory Analysis - Dysphagia

Source : https://link.springer.com/article/10.1007/s00455-022-10473-x

Both chronic obstructive pulmonary disease (COPD) and dysphagia can be complicated by the shared physiological-psychoemotional manifestations of the conditions, such as anxiety and respiratory dysfunction. Despite their shared comorbidities, clinical...



Conclusion: Ultimately, to promote patient-centered care, we need to view the oral intake experience for individuals with COPD through a more comprehensive lens that incorporates the interrelationships between the physiological and psychoemotional manifestations of COPD and better educate patients on COPD’s impact on eating and drinking.

  • Saved
Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease - PubMed

Comparative Study on the effectiveness of Glycopyrrolate/Formoterol versus Tiotropium/Formoterol in patients with Chronic Obstructive Pulmonary Disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35707484/

doi: 10.1016/j.conctc.2022.100931. 1 Department of Respiratory Medicine, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India. 2 Department of Pharmacy Practice,...



Conclusion: Non-inferiority of GFF when compared to TFF was established along with good tolerability and comparable adverse effect profile.

  • Saved
Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review - PubMed

Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35713962/

doi: 10.1080/17476348.2022.2092099. Online ahead of print. 1 Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany. 2 Biomedical Research in Endstage and Obstructive Lung Disease, Member of the German Center...



Expert opinion: Despite remaining challenges, personalised medicine has the potential to offer tailored approaches to prevention and therapy and promises to improve the care of patients living with COPD.

  • Saved
Effectiveness of COPD treatment with the combination of tiotropium/olodaterol in Polish standard clinical practice as measured by the improvement of CCQ: an observational study - PubMed

Effectiveness of COPD treatment with the combination of tiotropium/olodaterol in Polish standard clinical practice as measured by the improvement of CCQ: an observational study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35635728/

Introduction: COPD health-related quality of life (HRQoL) can be measured by the Clinical COPD Questionnaire (CCQ). In this study the CCQ was used to assess the therapeutic success of fixed-dose...


Conclusions: Tiotropium/olodaterol treatment improved clinical control in Polish COPD patients. The therapeutic success was the most pronounced in patients with more severe COPD and in the treatment-naive but occurred also in those with moderate disease and in previously treated subjects.

  • Saved
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration - PubMed

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/35665728/

1 Kanagawa Cardiovascular and Respiratory Center, Department of Respiratory Medicine, Kanazawa-ku, Yokohama, Japan. 2 Kanagawa Cancer Center, Department of Thoracic Oncology, Asahi-ku, Yokohama, Japan. 3 Kanagawa Cardiovascular and Respiratory Center,...


Conclusions: Clinical trials verifying the use of pirfenidone after disease progression in IPF may be difficult to enroll patients. Definitive conclusions on both safety and efficacy cannot be drawn from the results of this study alone.